Philips to Sell Emergency Care Business to Bridgefield Capital
The move aligns with Philips' strategy to focus on areas with greater financial and operational impact.
Royal Philips has announced an agreement to sell its Emergency Care business to Bridgefield Capital, a US-based investment firm.
The move aligns with Philips' strategy to focus on areas with greater financial and operational impact.
Philips and its Emergency Care business will enter into an exclusive brand license agreement, allowing the continued use of the Philips brand for the manufacturing, sales, and marketing of Emergency Care products globally for up to 15 years.
The Emergency Care division, part of Philips' Connected Care segment, provides essential acute care solutions, including automated external defibrillators and emergency care devices used in both professional and consumer settings.
As part of its 2023 strategic realignment, Philips assessed various options for the Emergency Care unit before deciding to divest to Bridgefield Capital.
The investment firm specializes in advising and supporting businesses to enhance growth and profitability.
The transaction is subject to regulatory approval and other closing conditions, with finalization expected in the second half of 2025. Financial details of the deal have not been disclosed.
